Citation Tools
PDFPharmacotherapy: pharmacokinetics and pharmacodynamics (including: ADE, TDM, DUE)
PHC-016 Nilotinib Versus Imatinib For the Treatment of Patients with Newly-Diagnosed Philadephia Chromosome-Positive, Chronic Myeloid Leukaemia in the Chronic Phase
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- PHC-016 Nilotinib Versus Imatinib For the Treatment of Patients with Newly-Diagnosed Philadephia Chromosome-Positive, Chronic Myeloid Leukaemia in the Chronic Phase